Maria M. Saraiva-Joao

Levels and instability of transthyretin and correlations with core biomarkers in Alzheimer's disease.

Journal: Scientific reports

Published: May 06, 2025

A novel approach for evaluating transthyretin kinetic stabilizers using plasma samples.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: February 14, 2025

Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: July 01, 2024

Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: March 22, 2023

Cellular environment of TTR deposits in an animal model of ATTR-Cardiomyopathy.

Journal: Frontiers in molecular biosciences

Published: January 13, 2023

TLR2 and 4 signaling pathways are altered in macrophages from V30M TTR mice with down-regulated expression of chemokines.

Journal: Clinical science (London, England : 1979)

Published: October 11, 2022

Selective recognition of human small transthyretin aggregates by a novel monoclonal antibody.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: September 16, 2022

Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis.

Journal: Journal of neuroinflammation

Published: July 23, 2021

Levels and instability of transthyretin and correlations with core biomarkers in Alzheimer's disease.

Levels and instability of transthyretin and correlations with core biomarkers in Alzheimer's disease.

A novel approach for evaluating transthyretin kinetic stabilizers using plasma samples.

A novel approach for evaluating transthyretin kinetic stabilizers using plasma samples.

Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis.

Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis.

Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis.

Decreased expression of S100A8/A9 in V30M related ATTRv amyloidosis.

Cellular environment of TTR deposits in an animal model of ATTR-Cardiomyopathy.

Cellular environment of TTR deposits in an animal model of ATTR-Cardiomyopathy.

TLR2 and 4 signaling pathways are altered in macrophages from V30M TTR mice with down-regulated expression of chemokines.

TLR2 and 4 signaling pathways are altered in macrophages from V30M TTR mice with down-regulated expression of chemokines.

Selective recognition of human small transthyretin aggregates by a novel monoclonal antibody.

Selective recognition of human small transthyretin aggregates by a novel monoclonal antibody.

Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis.

Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis.

In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis.

In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis.

The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.

The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.

A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells.

A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells.

Modulation of the Mechanisms Driving Transthyretin Amyloidosis.

Modulation of the Mechanisms Driving Transthyretin Amyloidosis.